LAM
RPRX icon

LECAP Asset Management’s Royalty Pharma RPRX Stock Holding History

LECAP Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,789
Closed -$275K – 381
2024
Q4 		$275K Sell
10,789
-25,366
-70% -$673K 0.07% 269
2024
Q3 		$1.02M Buy
+36,155
New +$1M 0.22% 162
2024
Q1 		– Sell
-20,093
Closed -$564K – 371
2023
Q4 		$564K Buy
+20,093
New +$552K 0.21% 183

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

LECAP Asset Management's RPRX Position: Q1 2025 in Review

LECAP Asset Management sold out of Royalty Pharma (RPRX) in Q1 2025, closing a stake of 10,789 shares — an estimated $275K sold.

LECAP Asset Management first reported a position in RPRX in Q4 2023 and held it in 3 quarters. The position peaked at $1.02M in Q3 2024. 447 funds tracked by Wall St. Rank hold RPRX as of Q1 2025.

  • LECAP Asset Management reported no remaining Royalty Pharma position as of Q1 2025 after selling out during the quarter.
  • LECAP Asset Management sold 10,789 Royalty Pharma shares in Q1 2025, an estimated $275K.
  • LECAP Asset Management first reported a position in Royalty Pharma in Q4 2023 and held it in 3 quarters.
  • LECAP Asset Management's Royalty Pharma position peaked at $1.02M in Q3 2024.
  • 447 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2025.

Based on LECAP Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.